Menopause significantly increases the risk of cardiovascular diseases in women due to a drop in estrogen levels.

The FDA’s recent approval of OZEMPIC highlights the expanding use of GLP-1 drugs beyond diabetes and weight management. Novo Nordisk’s blockbuster medication has gained another label expansion, now ...

Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.

Instead, a different type of medication called thiazide diuretics may work better and cause fewer side effects. Doctors have ...

High blood pressure is a major risk factor for heart disease. Here are some common questions you may have about blood ...

For example, some blood pressure medications – such as ACE inhibitors and angiotensin II receptor blockers (ARBs) – improve ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

For example, some blood pressure medications – such as ACE inhibitors and angiotensin II receptor blockers (ARBs) – improve ...

For example, some blood pressure medications - such as ACE inhibitors and angiotensin II receptor blockers (ARBs) - improve brain health by enhancing blood flow and reducing inflammation. On the other ...

Objectives ACE inhibitors (ACEI) are underutilised despite cardiovascular benefits, in part due to concerns of known transient elevations in serum creatinine (SCr) after initiation. Our objectives ...

14 and Review Manager V.5.3. Cardiovascular mortality was reduced in beta-blocker therapy compared with controls (RR: 0.75, 95% CI: 0.60 to 0.94, p=0.01, n=1046), whereas ACE inhibitors (RR: 0.94, 95% ...